Role of Homoeopathic Medicines in the treatment of Bacterial Vaginosis

Evaluating the effectiveness of Oral Individualized Homoeopathic Medicines Versus Hydrastis Canadensis Tincture as a local application in the treatment of Bacterial Vaginosis: An open label Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093375

Enrollment

Registered

2025-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

Intervention1: Individualized Homoeopathic Medicines: Individualized Homoeopathic Medicines will be administered in centesimal potencies, selected according to homoeopathic principles. The dose and

Eligibility

Inclusion criteria

Inclusion criteria: 1. women of age group 18-45 years. 2. Women presenting with sign and symptoms of Bacterial Vaginosis as per Amsel?s and Nugent Scoring

Exclusion criteria

Exclusion criteria: 1. Pregnancy or Lactation: Women who are pregnant or breastfeeding. 2. Concurrent Vaginal Infections: Presence of other sexually transmitted infections. 3. Severe Comorbidities: Significant medical conditions (e.g., diabetes, immunosuppression) that could affect treatment outcomes. Recent Surgical Procedures: Any recent gynecological surgeries or interventions. 4. Hormonal Treatments: Use of hormonal therapies (e.g., contraceptives, hormone replacement therapy) that may influence vaginal flora. 5. Uncontrolled Medical Conditions: Any uncontrolled systemic conditions that could impact health or treatment efficacy. 6. Allergies to Study Remedies: Known allergies or sensitivities to any homoeopathic remedies being tested. 7. Non-compliance Risk: Individuals who may not adhere to the study protocol or followup requirements.

Design outcomes

Primary

Measure	Time frame
1. This trial is expected to indicate that individualized homoeopathic medicines will have greater therapeutic benefits as compared to Hydrastis Canadensis in treatment of Bacterial VaginosisTimepoint: 11 months	—

Secondary

Measure	Time frame
1.This study aims to identify a group of most effective homeopathic medicine in the management of Bacterial Vaginosis 2.The study anticipates that homeopathic medicine will show positive effects by improving Amsel?s criteria and Nugent?s score in the treatment of Bacterial Vaginosis 3.This study intends to explore the effectiveness of individualized homeopathic remedies in providing long-term relief and preventing the recurrence of Bacterial VaginosisTimepoint: 11 months	—

Measure

Time frame

1.This study aims to identify a group of most effective homeopathic medicine in the management of Bacterial Vaginosis 2.The study anticipates that homeopathic medicine will show positive effects by improving Amsel?s criteria and Nugent?s score in the treatment of Bacterial Vaginosis 3.This study intends to explore the effectiveness of individualized homeopathic remedies in providing long-term relief and preventing the recurrence of Bacterial VaginosisTimepoint: 11 months

—

Countries

India

Contacts

Public ContactDr Divya Bharti

Dr B R Sur Homoeopathic Medical College Hospital and Research Centre

Shmc.thyroidclinic@gmail.com9871347553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026